National Center for Research Resources (NCRR): Arthritis trials

The registry lists 15 Arthritis studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the BoneCompletedNCT00007046
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisStatus unknownNCT00006393
• Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus NurtureCompletedNCT00006134
• Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus ErythematosusCompletedNCT00006133Not applicable
• Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT00004795Phase 2/3
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
• Study of Individualized Instruction Versus Pamphlet in Systemic Lupus ErythematosusCompletedNCT00004756Not applicable
• Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus ErythematosusCompletedNCT00004665Phase 2
• Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus ErythematosusCompletedNCT00004663
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus ErythematosusCompletedNCT00004662Phase 3
• Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus ErythematosusCompletedNCT00004643Phase 2
• Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2
• Ultraviolet Light Therapy for Systemic Lupus ErythematosusStatus unknownNCT00004375Phase 2
• Study of Systemic Amyloidosis Presentation and PrognosisStatus unknownNCT00004374
• Phase II Study of Calcitonin for Tumoral CalcinosisCompletedNCT00004358Phase 2